8,720 Shares in Colgate-Palmolive (NYSE:CL) Acquired by Peak Retirement Planning Inc.

Peak Retirement Planning Inc. acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 8,720 shares of the company's stock, valued at approximately $792,000.

Several other large investors have also added to or reduced their stakes in CL. North Star Asset Management Inc. boosted its stake in shares of Colgate-Palmolive by 24.8% during the 4th quarter. North Star Asset Management Inc. now owns 8,798 shares of the company's stock worth $800,000 after buying an additional 1,750 shares during the last quarter. Parr Mcknight Wealth Management Group LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $2,192,000. Pacific Point Advisors LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $1,283,000. Vise Technologies Inc. boosted its holdings in shares of Colgate-Palmolive by 64.3% in the 4th quarter. Vise Technologies Inc. now owns 17,586 shares of the company's stock valued at $1,599,000 after buying an additional 6,883 shares during the last quarter. Finally, Orion Capital Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $91,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

CL stock traded up $0.28 during mid-day trading on Thursday, hitting $92.04. The stock had a trading volume of 1,942,598 shares, compared to its average volume of 4,677,181. The firm has a fifty day simple moving average of $91.93 and a 200 day simple moving average of $91.26. The firm has a market capitalization of $74.59 billion, a P/E ratio of 26.14, a P/E/G ratio of 4.20 and a beta of 0.39. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same period last year, the firm posted $0.86 earnings per share. The firm's quarterly revenue was down 3.0% compared to the same quarter last year. As a group, research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive declared that its Board of Directors has approved a share buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to purchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board believes its shares are undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date was Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's payout ratio is currently 58.76%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research analyst reports. Citigroup lifted their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Wall Street Zen cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Barclays cut their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, April 11th. Finally, Raymond James reaffirmed an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $102.12.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.